Search

Search Results

• Effect of Bruton Tyrosine Kinase Inhibitors on T-Lymphocytes and Tumor Microenvironment Cells in B-Cell Lymphoproliferative Diseases

  Yuliya Sergeevna Efremova, T.V. Glazanova, N.A. Romanenko

  320-326

  01.07.2026

• Blastoid Variant of Cyclin D1-Negative Mantle Cell Lymphoma in a Female Patient with 46,XY Disorder of Sex Development: A Rare Case Report

  Natalia Vyacheslavovna Oparina, T.V. Davidian, E.A. Mamaeva, N.G. Chernova, L.A. Tsapkova, N.A. Bodunova

  353-362

  01.07.2026

• High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in the Third- and Subsequent-Line Therapy for Relapsed/Refractory Classical Hodgkin Lymphoma

  Vladislav Olegovich Sarzhevskiy, Yu.V. Protopopova, N.E. Mochkin, E.A. Demina, A.A. Mamedova, A.A. Samoylova, V.S. Bogatyrev, A.A. Rukavisyn, E.G. Smirnova, N.S. Shorokhov, A.E. Bannikova, V.Ya. Melnichenko

  310-319

  01.07.2026

• Level and Serum Metabolism of Homocysteine in Chronic Myeloid Leukemia Patients: A Literature Review

  K.S. Samarina, Yuliana Yurevna Assesorova, I.V. Berger

  162-171

  01.04.2026

• NK-Cell Receptor Repertoire in Chronic Myeloid Leukemia

  Tamara Vangelevna Chitanava, R.A. Vlasik, L.O. Khordzhasov, A. Ataman, N.S. Luchkina, A.Yu. Aronov, I.D. Matvienko, N.T. Siordiya, O.V. Kulemina, N.S. Lazorko, E.I. Sbityakova, N.A. Shnalieva, E.N. Tochenaya, J.A. Alekseeva, P.A. Butylin, S.V. Smirnov, Yu. A. Zaritskii, Yu.P. Martinova, E.G. Lomaia

  152-161

  01.04.2026

• Results of a Double-Blind Prospective Comparative Randomized Phase 3 Clinical Trial of the Efficacy and Safety of BCD-264 and Darzalex as Monotherapy for Relapsed/Refractory Multiple Myeloma (BCD-264-2/DARVIVA)

  T.V. Shelekhova, J. Kumar, S.J. Apte, Iu.S. Osipov, E.N. Misyurina, V.A. Doronin, T.S. Konstantinova, B.A. Bakirov, A.V. Proidakov, A.L. Uss, M. Kumar, E.V. Martynova, N.G. Chernova, M.A. Khokhar, A.D. Garifullin, C.R. Ross, S.L. Cyriac, S.V. Voloshin, M.A. Ulyanova, N.A. Falaleeva, N.A. Katin, D.V. Kirtbaya, M.O. Kiseleva, E.Yu. Komarceva, A.A. Myasnikov, D.K. Novik, M. Shabbir-Moosajee, S.V. Samarina, V.V. Denisova, G.N. Khusainova, T.K. Dolai, B. Bagchi, I.S. Zyuzgin, I.S. Moiseev, T.I. Pospelova, A.A. Semenova, M.A. Novikova, I.L. Davydkin, M.V. Kosinova, A.M. Pavlova, N. Sidharthan, H. Mukhopadhyay, A. Wahid, Q.M. Buttar, Yu.N. Linkova, A.V. Zinkina-Orikhan, Svyatoslav Vladimirovich Nechaev, A.S. Shadrina, A.A. Lutckii, D.O. Liaptseva

  119-130

  01.04.2026

• Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma: A Literature Review and Our Own Experience

  Ulyana Gordeevna Koshkina, A.A. Semenova, M.Yu. Kichigina, D.N. Tupitsyna, V.O. Shpirko, A.I. Cherencova, S.F. Ramazanova, N.O. Zemlyakov, I.Z. Zavodnova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, G.S. Tumyan

  59-69

  01.01.2026

• Bruton Tyrosine Kinase Inhibitors for the Treatment of Relapsed Mantle Cell Lymphoma Involving CNS: Two Case Reports and Literature Review

  Evgenii Olegovich Kunevich, N.N. Nemstsveridze, M.A. Mikhaleva, A.Yu. Kuvshinov, T.V. Ovchinnikova, E.V. Koryakina, S.V. Samarina, K.Yu. Krutikova, S.V. Sidorkevich, S.V. Voloshin

  184-196

  01.04.2025

• Functional Cure as a New Concept of Therapy for Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  105-120

  01.04.2025

• Options for Program Chemotherapy and Their Outcomes in Patients with Newly Diagnosed Mantle Cell Lymphoma Based on the Data from a Single Center

  Ulyana Gordeevna Koshkina, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, N.A. Kupryshina, E.A. Osmanov

  121-133

  01.04.2025

• Current Strategy and Principles of Multiple Myeloma Treatment: A Literature Review

  Aleksander Sergeevich Luchinin, A.A. Semenova, S.V. Semochkin

  153-162

  01.04.2025

• Personalized Approach to Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients with Respect to Molecular Landscape: A Case Report and Literature Review

  Marat Albertovich Mingalimov, E.A. Baryakh, T.N. Tolstykh, A.V. Misyurin, L.A. Kesaeva, A.S. Mkrtchyan, A.M. Kovrigina, E.N. Misyurina, M.S. Orlova, T.S. Chudnova, D.D. Ivanova, O.L. Kochneva, S.S. Andreev, K.V. Yatskov, I.V. Samsonova, M.A. Lysenko

  177-183

  01.04.2025

• Iron Metabolism in Patients with Paroxysmal Nocturnal Hemoglobinuria: Results of a Single-Center Ambispective Clinical Trial

  Vitalii Dmitrievich Latyshev, K.A. Jennewein, A.A. Soloveva, A.E. Kitsenko, N.V. Tsvetaeva, E.A. Lukina

  1-9

  01.01.2025

• The Role of Somatic Mutations in Various Genes and the Issue of Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: A Literature Review

  Elena Andreevna Kuzmina, E.Yu. Chelysheva, B.V. Biderman, A.G. Turkina

  10-20

  01.01.2025

• Interim Results of the Russian Prospective Multi-Center Clinical Trial READIT-2020 (Reduction of Tyrosine Kinase Inhibitor Doses in CML Patients, Plasma Imatinib/Nilotinib Concentrations, Sustaining Molecular Response, and Drug Toxicity)

  Margarita Anatolevna Gurianova, V.I. Kazey, O.A. Shukhov, E.Yu. Chelysheva, A.G. Nikiforova, P.D. Sobolev, M.S. Dolov, D.Yu. Grebenkin, A.N. Petrova, A.V. Bykova, I.S. Nemchenko, E.A. Kuzmina, L.V. Gavrilova, A.V. Kokhno, A.G. Turkina

  347-359

  01.10.2024

• Sarcoid-like Pulmonary Lesion in a Female Patient with Multiple Myeloma and Systemic AL Amyloidosis Treated with Daratumumab: A Case of Spontaneous Regression of Lung Tissue Changes upon Drug Withdrawal

  Irina Germanovna Rekhtina, V.A. Khyshova, A.M. Kovrigina, M.A. Silaev, L.P. Mendeleeva

  370-375

  01.10.2024

• Response-Adapted Strategy in the Treatment of Primary Mediastinal Large B-Cell Lymphoma: Results of a Prospective Single-Center Clinical Trial

  Yana Konstantinovna Mangasarova, R.R. Abdurashidova, A.U. Magomedova, O.V. Margolin, E.S. Nesterova, L.G. Gorenkova, M.O. Bagova, E.A. Fastova, D.S. Belkina, A.M. Kovrigina, N.G. Gabeeva, D.A. Koroleva, S.K. Kravchenko, Yu.A. Chabaeva, E.E. Zvonkov

  335-346

  01.10.2024

• Treatment Outcomes in Primary Mediastinal Large B-Cell Lymphoma. Experience of the AF Tsyb Medical Radiological Research Center (Obninsk)

  Alena Yurevna Terekhova, N.A. Falaleeva, A.B. Galitsyna, A.M. Chelmakov, A.A. Vovchenko, N.A. Riabikina, A.A. Danilenko, T. I. Bogatyreva

  225-236

  01.07.2024

• Nivo-DHAP Combined with Subsequent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Multi-Center Prospective Clinical Trial (ClinicalTrials.gov, NCT04091490)

  V.O. Sarzhevskii, Aisel Akifovna Mamedova, N.E. Mochkin, E.A. Demina, A.A. Spornik, A.A. Samoilova, V.S. Bogatyrev, A.A. Rukavitsyn, E.G. Smirnova, N.S. Shorokhov, A.E. Bannikova, V.Ya. Melnichenko, N.B. Mikhailova, E.S. Borzenkova, L.V. Stelmakh, Yu.R. Zalyalov, A.A. Semenova, G.S. Tumyan, M.A. Danilova, O.A. Konova, N.A. Falaleeva, AYu Terekhova, M.A. Vernyuk, A.M. Chervontseva, L.S. Khairullina, A.A. Maslov, I.B. Lysenko, Yu.A. Alekseeva, E.S. Pavlyuchenko, A.A. Mirsaitov, A.A. Zverkova, I.V. Ishmatova, S.A. Volchenkov, M.S. Motalkina, I.S. Zyuzgin

  1-10

  17.05.2024

• Cardiovascular Complications of the Immunotherapy of Hematological Malignancies: A Literature Review

  Geliya Rifkatovna Gimatdinova, O.E. Danilova, V.P. Kuzmin, G.I. Davydkin, Yu.V. Kostalanova, D.A. Kudlai, I.L. Davydkin

  407-412

  28.09.2023

• Treatment Outcomes with Asciminib, the First Allosteric BCR::ABL1 Tyrosine Kinase Inhibitor, in Chronic Myeloid Leukemia Patients with Multiple Resistance to Prior Therapy

  A.G. Turkina, Elena Andreevna Kuzmina

  311-320

  09.06.2023

• Multiple Myeloma Complicated by Bone Plasmacytomas: Pathogenesis, Clinical Features, Treatment Approaches (A Literature Review)

  Elizaveta Andreevna Mamaeva, M.V. Solov’eva, L.P. Mendeleeva

  303-310

  09.06.2023

• Nivo-BeGEV as Preparation for Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Multi-Center Prospective Clinical Study

  Yana Konstantinovna Mangasarova, T.N. Moiseeva, O.V. Margolin, L.G. Gorenkova, E.S. Nesterova, F.E. Babaeva, M.O. Bagova, E.A. Fastova, R.R. Abdurashidova, L.S. Al-Radi, E.I. Dorokhina, E.M. Volodicheva, V.A. Lapin, O.S. Samoilova, S.K. Kravchenko, A.U. Magomedova, E.E. Zvonkov

  280-286

  09.06.2023

• Classical Hodgkin Lymphoma: Tumor Structure and Prognostic Value of the Immune Microenvironment

  Artem Aleksandrovich Gusak, K.V. Lepik, L.V. Fedorova, V.V. Markelov, V.V. Baykov

  242-262

  09.06.2023

• Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  229-241

  09.06.2023

• KIR-Genetic Factors and Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

  Elena Vital’evna Kuzmich, I.E. Pavlova, L.N. Bubnova, S.S. Bessmeltsev

  119-127

  03.03.2023

• Efficacy and Toxicity of Induction Therapy in Patients with Newly Diagnosed Systemic AL Amyloidosis: Results of a Prospective Single-Center Clinical Study

  I.G. Rekhtina, Viktoriya Aleksandrovna Khyshova, M.V. Solov’ev, L.P. Mendeleeva

  166-173

  03.03.2023

• Ibrutinib Efficacy in First-Line Therapy of High-Risk Patients Vs. Second- and Third-Line Therapies of Resistant Chronic Lymphocytic Leukemia

  Nadezhda Viktorovna Kurkina, E.A. Repina, P.V. Volkova, A.A. Repin

  209-212

  03.03.2023

• Combination of Ibrutinib and Venetoclax in the Therapy of Chronic Lymphocytic Leukemia: A Review of the Latest Data from Clinical Studies

  A.A. Petrenko, Mariya Igorevna Kislova, E.A. Dmitrieva, E.A. Nikitin, V.V. Ptushkin

  37-45

  01.01.2023

• Gilteritinib as a New Option for the Treatment of Relapsed/Refractory Acute Myeloid Leukemias with FLT3 Gene Mutation: A Literature Review and Three Case Reports

  D.V. Motorin, L.L. Girshova, E.G. Lomaia, Yu.A. Alekseeva, A.V. Petukhov, V.V. Ivanov, E.K. Antonov, S.V. Efremova, A.I. Reshetova, E.N. Tochenaya, Aleksina Alekseevna Shatilova, E.N. Tochenaya, A.V. Petrov, T.S. Nikulina, K.V. Bogdanov, D.V. Ryzhkova, Yu.V. Mirolyubova, I.E. Prokop’ev, I.G. Budaeva

  69-79

  01.01.2023

• Efficacy of Combined Drug Pre-transplant Conditioning Regimens in Multiple Myeloma Patients with Single Autologous Hematopoietic Stem Cell Transplantation

  Ivan Ivanovich Kostroma, A.S. Zhuk, Zh.Yu. Sidorova, R.R. Sabitova, A.Yu. Aksenova, O.B. Belopolskaya, S.S. Bessmeltsev, S.V. Sidorkevich, S.V. Gritsaev

  88-95

  01.01.2023

• CAR-T Therapy of Multiple Myeloma, Based on the Congresses ASH-2021 and ASCO-2022

  Sergei Vyacheslavovich Semochkin

  1-13

  01.01.2023

• Asciminib in Chronic Myeloid Leukemia Patients Without Therapeutic Alternatives: Results of the MAP (Managed Access Program, NCT04360005) Trial in Russia

  A.G. Turkina, Elena Andreevna Kuzmina, E.G. Lomaia, E.V. Morozova, E.Yu. Chelysheva, O.A. Shukhov, A.N. Petrova, T.V. Chitanava, Yu.Yu. Vlasova, I.S. Nemchenko, A.V. Bykova, E.I. Sbityakova, M.A. Gurianova, N.N. Tsyba, A.V. Kokhno, E.N. Parovichnikova

  54-68

  01.01.2023

• Efficacy Predictors of the Third-Line Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase of Chronic Myeloid Leukemia: Results of a Multi-Center Study

  E.G. Lomaia, V.A. Shuvaev, Tamara Vangelevna Chitanava, Yu.D. Matvienko, I.S. Martynkevich, S.V. Voloshin, E.V. Efremova, E.S. Mileeva, M.S. Fominykh, A.E. Kersilova, E.V. Karyagina, N.V. Il’ina, N.V. Dorofeeva, N.V. Medvedeva, A.V. Klimovich, T.V. Shneider, S.A. Stepanova, N.F. Polezhaikovskaya, N.T. Siordiya, E.I. Sbityakova, N.S. Lazorko, E.N. Tochenaya, D.V. Motorin, N.A. Shnalieva, Yu.A. Alekseeva, D.B. Zammoeva, A.Yu. Zaritskey

  271-281

  01.07.2022

• Russian Prospective Non-Randomized Clinical Study on Dose Reduction of Tyrosine Kinase Inhibitors with Subsequent Complete Therapy Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response (READIT-2020): Background, Aim, Mai

  A.G. Turkina, Margarita Anatolevna Gurianova, E.Yu. Chelysheva, O.A. Shukhov

  54-61

  01.01.2022

• Biological Mechanisms of Sustaining Deep Molecular Response in Chronic Myeloid Leukemia Upon Withdrawal of Tyrosine Kinase Inhibitors

  Ekaterina Yurevna Chelysheva, M.A. Guryanova, A.G. Turkina

  427-435

  01.10.2021

• Langerhans Cell Histiocytosis in Adults: Treatment Opportunities of Today

  Vitalii Dmitrievich Latyshev, E.A. Lukina

  444-454

  01.10.2021

• Prediction of Treatment Efficacy in Relapsed Chronic Lymphocytic Leukemia

  Olga Borisovna Kalashnikova, I.S. Moiseev, T.L. Gindina, E.A. Izmailova, M.O. Ivanova, E.V. Kondakova, N.B. Mikhailova, A.D. Kulagin

  466-476

  01.10.2021

• Treatment of Mastocytosis: A Literature Review

  Karina Maksimovna Chernavina, A.S. Orlova, E.A. Nikitin

  361-369

  01.07.2021

• Opportunities of Chronic Myeloid Leukemia Treatment with Reduced Doses of Tyrosine Kinase Inhibitors

  Margarita Anatolevna Guryanova, E.Yu. Chelysheva, A.G. Turkina

  118-128

  01.01.2021